The public health future of melanoma control - 20/10/11
Doi : 10.1016/j.jaad.2011.02.036
Howard K. Koh, MD, MPH a, Alan C. Geller, MPH, RN b, ⁎ 
a US Department of Health and Human Services, Washington, DC
b Department of Society, Human Development, and Health, Harvard School of Public Health, Boston, Massachusetts
Reprint requests: Alan C. Geller, MPH, RN, Department of Society, Human Development, and Health, Harvard School of Public Health, Kresge Building, 677 Huntington Avenue, Room 718, Boston, MA 02115.Key words : cancer control, cancer prevention, commentary, dermatology, melanoma, public health
Abbreviations used : CDC, NCI, UV
Le texte complet de cet article est disponible en PDF.
| Publication of this supplement to the JAAD was supported by the Division of Cancer Prevention and Control, Centers for Disease Control and Prevention (CDC). |
|
| Conflicts of interest: None declared. |
|
| The opinions or views expressed in this supplement are those of the authors and do not necessarily reflect the opinions, recommendations, or official position of the journal editors or the Centers for Disease Control and Prevention. |
© 2011
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 65 - N° 5S1
P. S3.e1-S3.e4 - novembre 2011 Retour au numéro
Article précédent
- Melanoma surveillance in the United States
- Marcus Plescia, Pamela Protzel Berman, Mary C. White
- Melanoma surveillance in the United States: Overview of methods
- Meg Watson, Christopher J. Johnson, Vivien W. Chen, Cheryll C. Thomas, Hannah K. Weir, Recinda Sherman, Myles Cockburn, Jeannette Jackson-Thompson, Mona Saraiya
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?